Patents by Inventor Man Fung Yuen

Man Fung Yuen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240153082
    Abstract: Disclosed is a computer-implemented three-dimensional image classification system (CIS) for processing and/or analyzing non-contrast computed tomography (CT) medical imaging data. The CIS is a deep neural network containing multiple Convolutional Block Attention Module (CBAM) blocks, which contain convolutional layers for feature extraction followed by CBAMs. The CBAM applies channel attention to highlight more relevant features and spatial attention to focus on more important regions. Max pooling layers operably link adjacent pairs of CBAM blocks. The output of the final CBAM block is passed to two terminal fully connected layers to generate a diagnosis. This classification system can be used to perform efficient diagnosis of hepatocellular carcinoma using solely non-contrast CT images, with diagnostic performance comparable to that of a radiologist using the current LIRADS system.
    Type: Application
    Filed: September 21, 2023
    Publication date: May 9, 2024
    Inventors: Chengzhi Peng, Leung Ho Philip Yu, Wan Hang Keith Chiu, Xianhua Mao, Man Fung Yuen, Wai Kay Walter Seto
  • Publication number: 20230154141
    Abstract: Disclosed are systems and methods using artificial intelligence for the detection and characterization of liver cancers.
    Type: Application
    Filed: March 23, 2021
    Publication date: May 18, 2023
    Inventors: Philip Leung Ho Yu, Keith Chiu, Man Fung Yuen, Wai Kay Walter Seto
  • Publication number: 20220333163
    Abstract: Disclosed are microbial biomarkers and methods for accurate non-invasive diagnosis of non-alcoholic fatty liver disease (NAFLD) in subjects. The microbial biomarkers include Lactococcus lactis as well as its strains and subspecies. The microbial biomarkers include Dorea sp. 5-2. The methods include measuring abundance or copy number of the one or more microbial biomarkers in a sample from the subject. The sample may be bodily fluid, mucus, or stool. Also described are methods of treating a subject with NAFLD by administering to the subject a composition containing Lactococcus lactis and/or Dorea sp. 5-2.
    Type: Application
    Filed: April 8, 2022
    Publication date: October 20, 2022
    Inventors: Hein Min Tun, Sai Sai Zhang, Hau Tak Chau, Fung Yu Huang, Man Fung Yuen, Wai Kay Seto
  • Publication number: 20220287647
    Abstract: A computer-implemented system (CIS), based on the DenseNet model, for processing and/or analyzing computer tomography (CT) medical imaging input data is described. The CIS contains two or more dense blocks containing one or more modules. Within each dense block, output from preceding modules containing convolutional layers are transmitted to succeeding modules containing convolutional layers, via a gate that is controlled by a predefined or trainable threshold. The CIS also includes transition layers between the dense blocks, operably linked to pairs of consecutive dense blocks in the series configuration. The CIS can be used in a computer-implemented method for enhanced diagnoses of hepatocellular carcinoma, based analysis of one or more CT medical images.
    Type: Application
    Filed: March 11, 2022
    Publication date: September 15, 2022
    Inventors: Leung Ho Philip Yu, Wenming Cao, Chiu Sing Gilbert Lui, Wan Hang Keith Chiu, Man Fung Yuen, Wai Kay Walter Seto
  • Patent number: 9879330
    Abstract: The present invention is a diagnostic kit and materials for: 1) the prediction of the long-term response of a chronic hepatitis B virus (HBV) carrier to treatment with nucleoside/nucleotide analog, or their combination; 2) the detection of HBV variants that exhibit reduced reactivity to antibody detection; 3) the detection of HBV variants in the precore/core region that negatively affect the course of liver disease; 4) the identification of the HBV genotype.
    Type: Grant
    Filed: March 31, 2009
    Date of Patent: January 30, 2018
    Assignee: VERSITECH LIMITED
    Inventors: Kaimin Chan, Vivian Nap Yee Chan, Ching Lung Lai, Man Fung Yuen
  • Publication number: 20090253123
    Abstract: The present invention is a diagnostic kit and materials for: 1) the prediction of the long-term response of a chronic hepatitis B virus (HBV) carrier to treatment with nucleoside/nucleotide analogue, or their combination; 2) the detection of HBV variants that exhibit reduced reactivity to antibody detection; 3) the detection of HBV variants in the precore/core region that negatively affect the course of liver disease; 4) the identification of the HBV genotype.
    Type: Application
    Filed: March 31, 2009
    Publication date: October 8, 2009
    Inventors: Kaimin Chan, Vivian Nap Yee Chan, Ching Lung Lai, Man Fung Yuen